
New Key Publication: Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile
BACKGROUND: In mice, GPR146 (G-protein–coupled receptor 146) deficiency reduces plasma lipids and protects against atherosclerosis. Whether these findings translate to humans is unknown.
METHODS: Common and rare genetic variants in the GPR146 gene locus were used as research instruments in the UK-Biobank. The Lifelines, and The Copenhagen-City Heart Study, and a cohort of individuals with familial hypobetalipoproteinemia were used to find and study rare GPR146 variants.
RESULTS: In the UK-Biobank, carriers of the common rs2362529-C allele present with lower low-density lipoprotein cholesterol, apo (apolipoprotein) B, high-density lipoprotein cholesterol, apoAI, CRP (C-reactive protein), and plasma liver enzymes compared with noncarriers. Carriers of the common rs1997243-G allele, associated with higher GPR146 expression, present with the exact opposite phenotype. The associations with plasma lipids of the above alleles are allele dose-dependent. Heterozygote carriers of a rare coding variant (p.Pro62Leu; n=2615), predicted to be damaging, show a stronger reductions in the above parameters compared with carriers of the common rs2362529-C allele. The p.Pro62Leu variant is furthermore shown to segregate with low low-density lipoprotein cholesterol in a family with familial hypobetalipoproteinemia. Compared with controls, carriers of the common rs2362529-C allele show a marginally reduced risk of coronary artery disease (P=0.03) concomitant with a small effect size on low-density lipoprotein cholesterol (average decrease of 2.24 mg/dL in homozygotes) of this variant. Finally, mendelian randomization analyses suggest a causal relationship between GPR146gene expression and plasma lipid and liver enzyme levels.
CONCLUSIONS: This study shows that carriers of new genetic GPR146 variants have a beneficial cardiometabolic risk profile, but it remains to be shown whether genetic or pharmaceutical inhibition of GPR146 protects against atherosclerosis in humans
- Antoine Rimbert
- Ming W. Yeung
- Nawar Dalila
- Chris H.L. Thio
- Haojie Yu
- Natalia Loaiza
- Federico Oldoni
- Adriaan van der Graaf
- Siqi Wang
- M. Abdullah Said
- Lisanne L. Blauw
- Aurore Girardeau
- Lise Bray
- Amandine Caillaud
- Vincent W. Bloks
- Marie Marrec
- Philippe Mouli
- Patrick C.N. Rensen
- Bart van de Sluis
- Harold Snieder
- Mathilde Di Filippo
- Pim van der Harst
- Anne Tybjaerg-Hansen
- Philippe Zimmerman
- Bertrand Cariou
- Jan Kuivenhoven
More Information: Arterioscler Thromb Vasc Biol 2022 Sep 1;101161ATVBAHA122317514. doi: 10.1161/ATVBAHA.122.317514. [Pubmed]
Last modified: | 05 September 2022 09.49 a.m. |
More news
-
24 March 2025
UG 28th in World's Most International Universities 2025 rankings
The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. In this podcast, Jouke de Vries, the chair of the Executive Board, looks back.